You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Med., 27 January 2023

Sec. Gastroenterology

Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1091788

Corrigendum: Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy

  • 1. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

  • 2. Department of Biology, University of Pisa, Pisa, Italy

  • 3. Research Center Nutraceuticals and Food for Health-Nutrafood, University of Pisa, Pisa, Italy

Article metrics

View details

1,5k

Views

484

Downloads

In the published article, there was an error in Table 2 as published. The total CFU of VSL3 in Table 2 was displayed as “4.53 ± 0.47 × 1013.” The correct total CFU of VSL3 is “4.53 ± 0.47 × 1012.” The total CFU of Codex in Table 2 was displayed as “2.68 ± 2.4 × 109.” The correct total CFU of Codex is “2.68 ± 2.40 × 109.” The corrected Table 2 and its caption appear below.

Table 2

Formulation Dose Labeled cell no. Total CFU CFU from spores only
Enterogermina 1 vial 2 × 109 1.15 ± 0.50 × 109 1.65 ± 0.71 × 109
Enterolactis Plus 1 capsule 2.4 × 1010 2.71 ± 0.30 × 1012
Lactoflorene Plus 1 bottle 2 × 109 6.02 ± 5.73 × 107 1.35 ± 1.50 × 107
Reuflor 5 drops 1 × 109 8.72 ± 1.53 × 1011
Codex 1 capsule 5 × 109 2.68 ± 2.40 × 109
Prolife 1 bottle 1.25 × 1011 2.16 ± 0.36 × 1011 3.51 ± 1.49 × 1010
Dicoflor 5 drops 5 × 109 9.65 ± 1.95 × 109
Enterelle 1 capsule 3 × 109 5.74 ± 0.99 × 1010
Yovis 1 sachet 2.97 × 1011 3.51 ± 3.13 × 1012
VSL3 1 sachet 4.5 × 1011 4.53 ± 0.47 × 1012

Enumeration of the organisms contained in a unit dose of each probiotic formulation.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

probiotics, microbial identification, MALDI-TOF, gastric juice, intestinal fluid, acid resistance, bile tolerance

Citation

Vecchione A, Celandroni F, Mazzantini D, Senesi S, Lupetti A and Ghelardi E (2023) Corrigendum: Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy. Front. Med. 9:1091788. doi: 10.3389/fmed.2022.1091788

Received

07 November 2022

Accepted

30 November 2022

Published

27 January 2023

Volume

9 - 2022

Edited and reviewed by

Angel Lanas, University of Zaragoza, Spain

Updates

Copyright

*Correspondence: Emilia Ghelardi ✉

This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics